Fukui N, Kohno Y, Ishioka JI, Fukuda H, Kageyama Y, Higashi Y. Treatment outcome of patients with extragonadal nonseminomatous germ cell tumors: the Saitama Cancer Center experience. Int J Clin Oncol. 18: 731-4, 2013. PubMed
Yasuda Y, Saito K, Yuasa T, Kitsukawa S, Urakami S, Yamamoto S, Yonese J, Takahashi S, Fukui I. Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Int J Clin Oncol. 18: 884-9, 2013.PubMed
Yasuda Y, Fujii Y, Yuasa T, Kitsukawa S, Urakami S, Yamamoto S, Yonese J, Takahashi S, Fukui I. Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma. Int J Clin Oncol. 18: 877-83, 2013.PubMed
Yasuda Y, Yuasa T, Yamamoto S, Urakami S, Ito M, Sukegawa G, Kitsukawa S, Yonese J, Fukui I. Evaluation of the RENAL Nephrometry Scoring System in Adopting Nephron-Sparing Surgery for cT1 Renal Cancer. Urol Int. 90: 179-83, 2013.PubMed
Bae H, Yoshida S, Matsuoka Y, Nakajima H, Ito E, Tanaka H, Oya M, Nakayama T, Takeshita H, Kijima T, Ishioka J, Numao N, Koga F, Saito K, Akashi T, Fujii Y, Kihara K. Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer. Int Urol Nephrol. 2013 [in press]
Fukui N, Kageyama Y, Higashi Y,Kihara K, Kizaka-Kondoh S, Hiraoka M, Shinojima T, Suzuki K, Oya M. Development of a novel interferon-α2b gene construct with a repetitive hypoxia-inducible factor binding site and its suppressive effects on human renal cell carcinoma cell lines in vitro. Int J Clin Oncol. 2013 [in press]
Fukushima H, Masuda H, Yokoyama M, Tatokoro M, Yoshida S, Ishioka J, Matsuoka Y, Numao N, Koga F, Saito K, Fujii Y, Kihara K. iabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma. Jpn J Clin Oncol. 43: 740-6, 2013.
Ito M, Masuda H, Kawakami S, Fujii Y, Koga F, Saito K, Yamamoto S, Yonese J, Fukui I, Kihara K. mpact of lower urinary tract symptoms on prostate cancer risk among Japanese men with prostate-specific antigen <10 ng/mL and non-suspicious digital rectal examination. Int J Urol. 20: 1163-8, 2013.
Kijima T, Koga F, Fujii Y, Yoshida S, Tatokoro M, Kihara K. Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1. PLoS One. 8: e64615, 2013.
Kobayashi S*, Fujii Y* (*equally contributed), Koga F, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Masuda H, Kihara K. Impact of bladder neck involvement on progression in patients with primary non-muscle invasive bladder cancer: a prospective validation study. Urol Oncol, 2013 [in press]
Kobayashi S, Koga F, Kajino K, Yoshida S, Ishii C, Tanaka H, Saito K, Masuda H, Fujii Y, Yamada T, Kihara K. Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. J Mag Reso Imaging. 39:172-8, 2013.
Koga F, Numao N, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K. Sensitivity to chemoradiation predicts development of metastasis in muscle-invasive bladder cancer patients. Urol Oncol. 7: 1270-5, 2013.
Komai Y, Sakai Y, Gotohda N, Kobayashi T, Kawakami S, Saito N. A novel 3-dimensional analysis system for case-specific kidney anatomy and surgical simulation to facilitate clampless partial nephrectomy. Urology. 83: 500-6, 2013
Komai Y, Numao N, Yoshida S, Matsuoka Y, Nakanishi Y, Ishii C, Koga F, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J Urol. 190(3):867-73, 2013.
Masuda H, Fukushima H, Kawakami S, Numao N, Fujii Y, Saito K, Koga F, Ishioka J, Yokoyama M, Kihara K. Impact of advanced age on biochemical recurrence after radical prostatectomy in Japanese men according to pathological stage. Jpn J Clin Oncol. 43:410-6, 2013.
Masuda H, Kagawa M, Kawakami S, Numao N, Matsuoka Y, Yokoyama M, Yamamoto S, Yonese J, Fukui I, Kihara K. Body mass index influences prostate cancer risk at biopsy in Japanese men. Int J Urol. 20:701-7, 2013.
Masuda H, Fukushima H, Kawakami S, Numao N, Fujii Y, Saito K, Koga F, Ishioka J, Yokoyama M, Kihara K. Impact of advanced age on biochemical recurrence after radical prostatectomy in Japanese men according to pathological stage. Jpn J Clin Oncol. 43:410-6, 2013.
Matsubara N, Mukai H, Naito Y, Itoh K, Komai Y, Sakai Y. First experience of active surveillance before systemic target therapy in patients with metastatic renal cell carcinoma. Urology. 82(1): 118-23, 2013.
Miyajima N, Tsutsumi S, Sourbier C, Beebe K, Mollapour M, Rivas C, Yoshida S, Trepel JB, Huang Y, Tatokoro M, Shinohara N, Nonomura K, Neckers L. The HSP90 inhibitor ganetespib synergizes with the MET kinase inhibitor crizotinib in both crizotinib-sensitive and -resistant MET-driven tumor models. Cancer Res. 73: 7022-33, 2013.
Moriyama S, Takeshita H, Adachi A, Arai Y, Higuchi S, Tokairin T, Chiba K, Nakagawa K, Noro A. Simultaneous bilateral testicular metastases from renal clear cell carcinoma: A case report and review of the literature. Oncol lett. 2013 [in press]
Naito S, Kinoshita H, Kondo T, Shinohara N, Kasahara T, Saito K, Takayama T, Masumori N, Takahashi W, Takahashi M, Terachi T, Ozono S, Naito S, Tomita Y. Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases: a multicenter study of 556 patients. Urology. 82:846-51, 2013.
Numao N, Yoshida S, Komai Y, Ishii C, Kagawa M, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Koga F, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. J Urol. 190:502-8, 2013.
Takeshita H, Numao N, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Koga F, Saito K, Masuda H, Kawakami S, Yamamoto S, Yonese J, Fujii Y, Kihara K. Diagnostic performance of initial transperineal 14-core prostate biopsy to detect significant cancer. Int Urol Nephrol. 45:645-52, 2013.
Takeshita H, Chiba K, Kitayama S, Moriyama S, Omura R, Noro A. Triplet chemotherapy with paclitaxel, gemcitabine, and cisplatin as second-line therapy for advanced urothelial carcinoma. Modern chemotherapy. 2:1-7, 2013.
Tatokoro M, Kihara K, Masuda H, Ito M, Yoshida S, Kijima T, Yokoyama M, Saito K, Koga F, Kawakami S, Fujii Y. Successful reduction of hospital-acquired methicillin-resistant Staphylococcus aureus in a urology ward: a 10-year study. BMC Urol. 18(13): 35,2013.
Yamamoto S, Fujii Y, Masuda H, Urakami S, Saito K, Kozuka T, Oguchi M, Fukui I, Yonese J. Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer. Qual Life Res. 2013 [in press]
Yamamoto S, Kawakami S, Yonese J, Fujii Y, Urakami S, Kitsukawa S, Masuda H, Ishikawa Y, Kozuka T, Oguchi M, Kohno A, Fukui I. Long-term oncological outcome in men with T3 prostate cancer: radical prostatectomy versus external-beam radiation therapy at a single institution. Int J Clin Oncol. 2013 [in press]
Yoshida S, Tsutsumi S, Muhlebach G, Sourbier C, Lee MJ, Lee S, Vartholomaiou E, Tatokoro M, Beebe K, Miyajima N, Mohney RP, Chen Y, Hasumi H, Xu W, Fukushima H, Nakamura K, Koga F, Kihara K, Trepel J, Picard D, Neckers L. Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis. Proc Natl Acad Sci U S A. 10:E1604-12, 2013.
Yoshida S, Kobayashi S, Koga F, Ishioka J, Ishii C, Tanaka H, Nakanishi Y, Matsuoka Y, Numao N, Saito K, Masuda H, Fujii Y, Kihara K. Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report. Eur Radiol. 23:2206-14, 2013.
Yuasa T, Kitsukawa S, Sukegawa G, Yamamoto S, Kudo K, Miyazawa K, Kozuka T,Harada S, Yonese J. Early onset recall pneumonitis during targeted therapy with sunitinib. BMC Cancer. 2013 Jan 2; 13: 3.
石岡淳一郎、齋藤一隆、古賀文隆、藤井靖久、有澤千鶴、鎌田成芳、森本信二、 辻井俊彦、 北原聡史、後藤修一、東 四雄、福井 巌、木原和徳. 上部尿路上皮癌術後の膀胱内再発予測モデル. 日本泌尿器科学会雑誌. 104(2):342, 2013.
影山幸雄、河野友亮、福井直隆、東 四雄、田中洋一. 膀胱上皮内癌に対する抗がん剤維持膀胱内注入療法の試み. 埼玉県医学会雑誌. 48(1):325-8, 2013.
Yokoyama M, Masuda H, Kihara K. Negative pressure wound therapy for surgical site infection associated with artificial urinary sphincter implantation. Int J Urol. 20: 1049-50, 2013.PubMed
北山沙知、入山哲次、高沢亮治、伊藤将也、木島敏樹、中西泰一、小林秀一郎、横山みなと、沼尾昇、兵地信彦、川上 理、 辻井俊彦. 立体14カ所生検所見に基づく前立腺癌積極的監視療法における再生検の意義. 泌尿器外科. 26:1249-52, 2013.
河野友亮、福井直隆、影山幸雄、東 四雄. Stage I 精巣癌のフォローアップにおける腫瘍マーカー測定の有用性:3症例の検討. 西日泌尿. 75:27-30, 2013.
河野友亮、福井直隆、影山幸雄、東 四雄. エンドトキシン吸着療法により救命しえたESBL産生菌による経直腸針生検後敗血症の一例. 泌尿紀要. 59:593-6, 2013.
河野友亮、影山幸雄、福井直隆、東 四雄、田中洋一. 前立腺全摘後に発症した上部尿路上皮癌の3例. 埼玉県医学会雑誌. 48(1):329-31, 2013.
古賀文隆、木原和徳、松岡 陽、沼尾 昇、齋藤一隆、増田 均. ミニマム創内視鏡下膀胱部分切除/骨盤リンパ節郭清を主軸とする浸潤性膀胱癌に対する新しい膀胱温存療法. Audio-Visual Journal of JUA. 19:19-10, 2013.
高沢亮治、北山沙知、辻井俊彦. 軟性腎盂尿管ビデオスコープを用いた特発性腎出血の診断. Audio-Visual Journal of JUA. 19(4):2013.
沼尾 昇、吉田宗一郎、横山みなと、石岡淳一郎、松岡 陽、古賀文隆、齋藤一隆、藤井靖久、伴 大輔、小林宏寿、小嶋一幸、木原和徳. ミニマム創内視鏡下手術の教育システムの実践. 泌尿器外科. 26(4):516-7, 2013.
福井直隆、河野友亮、小川一栄. 画像診断による発見が困難であった後腹膜脂肪肉腫. 臨床泌尿器科. 67:618-22,2013.
福井直隆、河野友亮、影山幸雄、東四雄、田中洋一. 当科における腎癌脳転移症例の検討. 埼玉県医学会雑誌. 48:332-4, 2013.
森山真吾、吉田宗一郎、竹下英毅、倉田盛人、岡田洋平、斎藤一隆、古賀文隆、増田 均、藤井靖久, 川上 理, 木原和徳. 拡散強調MR画像にて高信号を呈した膀胱炎症性病変の1例.組織学的所見との比較による考察. 日本泌尿器科学会雑誌. 104:545-8, 2013.